Cat:GMP-IVD-P042-Tg001
* GeneMedi provides NON-PROFIT PRICE to support Academic research. Please click inquiry for product quotation. → Inquiry
SKU GMP-IVD-P042-Tg001 Categories , Tag

Product Details

Genemedi produces core diagnostic ingredients for test of Infectious disease (Streptococcus pyogenes infection) and related syndrome. GeneMedi offers paired diagnostics grade streptolysin O (streptolysin O) antibodies (monoclonal antibody, mab) and antigens for Infectious disease (Streptococcus pyogenes infection) rapid test kit of streptolysin O (streptolysin O) testing in standard substance, positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT. All the antibodies and antigens for Infectious disease (Streptococcus pyogenes infection ) test are suitable for in functional ELISA, and other immunoassays in dignostics.The antibodies can act as a capture antibody and detection antibody. The antigens can be used as positive control.Anti-streptolysin O (anti-SLO, ASO) is an antibody targeted against streptolysin O, a toxic enzyme produced by group A Streptococcus bacteria. ASO and anti-DNase B are the most common of several antibodies that are produced by the body’s immune system in response to a strep infection with group A Streptococcus. This test measures the amount of ASO in the blood. Group A Streptococcus (Streptococcus pyogenes) is the bacterium responsible for causing strep throat and a variety of other infections, including skin infections (pyoderma, impetigo, cellulitis). In most cases, strep infections are identified and treated with antibiotics, and the infections resolve. When a strep infection does not cause identifiable symptoms, goes untreated, or is treated ineffectively, however, complications, namely rheumatic fever and a type of kidney disease (glomerulonephritis), can sometimes develop, especially in young children. These secondary conditions have become much less prevalent in the U.S. because of routine strep testing, but they still do occur. These conditions can cause serious complications such as heart damage, acute kidney dysfunction, tissue swelling (edema), and high blood pressure (hypertension). The ASO test can be used to help determine if these are due to a recent group A strep infection.

Product Description

Cat No. of Pruducts

GMP-IVD-P042-Tg001-Ag01:Recombinant streptolysin O (SLO) streptolysin O Protein

Product Name

Recombinant streptolysin O (SLO) streptolysin O Protein

Target

streptolysin O

Alias of Target/Biomarker

#N/A

Expression platform

E.coli

Isotypes

Recombinant Antigen

Bioactivity validation

streptolysin O (streptolysin O) antibodies binding, Immunogen in Sandwich Elisa, lateral-flow tests, and other immunoassays as control material in streptolysin O level test of Infectious disease (Streptococcus pyogenes infection) and related syndrome evaluation

Tag

His

Products description

Recombinant streptolysin O (SLO) streptolysin O Protein was expressed in E.coli -based prokaryotic cell expression system and is expressed with 6 HIS tag at the C-terminus.

Reconized/Reactive Species

streptolysin O (SLO)

Purity

Purity: ≥95% (SDS-PAGE)

Application

Standard substance, positive control, ELISA test,Lateral flow immunoassay (LFIA),colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA),turbidimetric inhibition immuno assay (TINIA),immunonephelometry and POCT.

Formulation

Supplied as a 0.2 μM filtered solution of PBS,PH7.4.

Storage

Store at -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.
Genemeidi Omicron Variant Products
test
Previous slide
Next slide

Cat No. of Pruducts

GMP-IVD-P042-Tg001-Ab01,GMP-IVD-P042-Tg001-Ab02:Anti-streptolysin O (SLO) streptolysin O mouse monoclonal antibody (mAb)

Product Name

Anti-streptolysin O (SLO) streptolysin O mouse monoclonal antibody (mAb)

Target

streptolysin O (SLO)

Alias of Target/Biomarker

#N/A

Expression platform

Hybridoma

Isotypes

Mouse IgG

Bioactivity validation

streptolysin O (SLO) streptolysin O (streptolysin O) antigen binding, ELISA validated as capture antibody and detection antibody. Pair recommendation with other streptolysin O (streptolysin O) antibodies in streptolysin O level test of Infectious disease (Streptococcus pyogenes infection) and related syndrome evaluation.

Tag

mFc

Products description

Anti-streptolysin O (SLO) streptolysin O mouse monoclonal antibody (mAb) is a mouse monoclonal antibody produced by hybridoma technology. The antibody is ELISA validated as capture antibody and detection antibody. Pair recommendation with other streptolysin O (streptolysin O) antibodies.

Reconized/Reactive Species

streptolysin O (SLO)

Purity

Purity: ≥95% (SDS-PAGE)

Application

ELISA test, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT

Formulation

Supplied as a 0.2 μM filtered solution of PBS,PH7.4.

Storage

Store at? -20℃ to -80℃ under sterile conditions. Avoid repeated freeze-thaw cycles.

Diagnostic antibodies and antigens for cancer detection - TG, CA-125, SCC Ag, PIVKA-Ⅱ, ProGRP, Calcitonin, NSE, CA-724, HE4, CA15-3, FER, CYFRA21-1, HER2, HSP90α, S100B, CEA, AFP, sFlt-1, PSA, hEGF, TFF2, TFF3, CA199, CA50, TK1

Regardless of the advances in the cancer therapy, delayed symptoms and lack of successful diagnosis of cancer at early stage increased the death rate. Tumor-associated antigens (TAAs) and their antibodies have been identified as potential markers in cancer diagnosis and determination. TAAs and their antibodies-based detection of cancer have the advantages such as low-cost, and simple access, which attracted much attention for early cancer detection. For several reasons, tumor marker itself is typically insufficient to analyze disease conditions. Because, maximum number of markers have been produced by both normal and cancer cells. Several cancers such as anal, breast, ovaries, testicles, colon, endometrial, peritoneal, fallopian tube, gallbladder, gastric, liver, lung, neuroendocrine, pancreatic, prostate, renal, cervix, stomach and thyroid cancer, bronchopulmonary dysplasia, hepatitis, hematological malignancies, hemochromatosis, hypercalcemia, osteoporosis, Parget’s diseases and so on have been identified using specific marker. Detecting the quantity of marker proteins from different samples may benefit from ELISA, Lateral flow immunoassay (LFIA), colloidal gold immunochromatographic assay, Chemiluminescent immunoassay (CLIA), turbidimetric inhibition immuno assay (TINIA), immunonephelometry and POCT.